Methyl 2-(3,5-dichloro-4-hydroxybenzamido)benzenesulfonate
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Methyl 2-(3,5-dichloro-4-hydroxybenzamido)benzenesulfonate

● In Stock

Catalogue No.:VE0025263
CAS No.:N/A
Mol. Formula:C14H11Cl2NO5S
Mol. Weight:376.21 g/mol

Additional information on Methyl 2-(3 | 5-dichloro-4-hydroxybenzamido)benzenesulfonate

Parent drug

Dotinurad

IUPAC Name

methyl 2-(3, 5-dichloro-4-hydroxybenzamido)benzenesulfonate

Pharmacopoeial Synonyms

N/A

Other Synonyms

N/A

Smiles

O=C(NC1=C(S(=O)(OC)=O)C=CC=C1)C2=CC(Cl)=C(O)C(Cl)=C2

InChI

InChI=1S/C14H11Cl2NO5S/c1-22-23(20, 21)12-5-3-2-4-11(12)17-14(19)8-6-9(15)13(18)10(16)7-8/h2-7, 18H, 1H3, (H, 17, 19)

Description

Methyl 2-(3 | 5-dichloro-4-hydroxybenzamido)benzenesulfonate is a process-related impurity typically generated via inadvertent esterification or methylation of a benzenesulfonic acid intermediate during methanol workup. It is chromophoric and amenable to characterization by reversed-phase HPLC with photodiode array detection and by LC-MS | where diagnostic fragments confirm the substituted dichloro aromatic pattern. Proton NMR reveals a methyl sulfonate resonance and aromatic signals consistent with 3 | 5-dichloro-4-hydroxy substitution. This impurity can influence final product purity | solubility and stability | therefore control strategies include optimized stoichiometry | minimized methanol exposure and targeted purification to meet ICH impurity thresholds.

Request a Quote

« * » indique les champs nécessaires

Ce champ n’est utilisé qu’à des fins de validation et devrait rester inchangé.
Products quotation
Name
Url